Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of NIAGEN in patients with systolic heart failure

Trial Profile

A study of NIAGEN in patients with systolic heart failure

Phase of Trial: Phase I

Latest Information Update: 22 Feb 2018

At a glance

  • Drugs Nicotinamide riboside (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 22 Feb 2018 New trial record
    • 20 Feb 2018 According to a ChromaDex media release, this trial is underway at the University of Washington and is expected to complete at the end of June, 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top